Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
SNN
STRONG BUYSmith & Nephew plc · Healthcare · United Kingdom · $12.9B · Avg Vol: $48M/d
81
StockRankGet insider-trade alerts
Q
71
V
39
M
65
P/E (TTM)
21.4x
ROE
11.8%
D/E
0.6x
Dividend %
1.3%
Loading 1Y...
PRICE (1Y)+1.8%
SMA 50SMA 200
Close
$31.12
RSI (14)
53.8
52W High
$37.90
From 52W High
0.8%
SCORE BREAKDOWN
Quality
71
ROIC
10.8%76.2
ROE
11.8%76.7
GP/Assets
40.2%80.7
Op. Margin
14.0%74.1
FCF/Assets
8.1%81.2
Piotroski
497.4
Int. Cover
5.4x52.6
D/E Ratio
0.63x25.5
Current Ratio
2.57x48.1
Value
39
P/E (TTM)
21.4x55.0
EV/EBITDA
50.7x10.8
P/FCF
15.1x70.3
P/B
12.3x9.3
P/S
2.1x66.7
Div Yield
1.3%33.1
Momentum
65
52W High %
82%74.2
RS 6M
-12%57.3
SMA 50/200
0.93x48.5
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+60%59.8
Q Growth
68%80.6
FUNDAMENTALS
Market Cap
$12.9B
P/E (Forward)
13.4x
Gross Margin
68.3%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of SNN are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| SNN | Smith & Nephew plc(you) | $12.9B | 81 | STRONG BUY |
| LIVN | LivaNova PLC | $4.3B | 80 | BUY |
| NIOX.L | NIOX Group Plc | $319M | 87 | STRONG BUY |
| EKF.L | EKF Diagnostics Holdings plc | $153M | 79 | BUY |
| KNSA | Kiniksa Pharmaceuticals International, plc | $4.8B | 87 | STRONG BUY |
| HLN.L | Haleon plc | $40.5B | 85 | STRONG BUY |
| HIK.L | Hikma Pharmaceuticals PLC | $4.3B | 89 | STRONG BUY |
| CTEC.L | Convatec Group PLC | $5.5B | 65 | BUY |
| IHC.L | Inspiration Healthcare Group plc | $27M | 69 | BUY |
| SPI.L | Spire Healthcare Group plc | $1.1B | 82 | STRONG BUY |
Peer medians: ROE -5.1% · P/E 24.9x · Gross margin 54.7%